These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12036886)

  • 1. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma.
    ten Berge RL; Meijer CJ; Dukers DF; Kummer JA; Bladergroen BA; Vos W; Hack CE; Ossenkoppele GJ; Oudejans JJ
    Blood; 2002 Jun; 99(12):4540-6. PubMed ID: 12036886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
    J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome.
    Dukers DF; Meijer CJ; ten Berge RL; Vos W; Ossenkoppele GJ; Oudejans JJ
    Blood; 2002 Jul; 100(1):36-42. PubMed ID: 12070005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-3 activation in systemic anaplastic large-cell lymphoma.
    Drakos E; Rassidakis GZ; Lai R; Herling M; O'Connor SL; Schmitt-Graeff A; McDonnell TJ; Medeiros LJ
    Mod Pathol; 2004 Jan; 17(1):109-16. PubMed ID: 14657946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic apoptotic pathway in anaplastic large cell lymphoma.
    Oyarzo MP; Drakos E; Atwell C; Amin HM; Medeiros LJ; Rassidakis GZ
    Hum Pathol; 2006 Jul; 37(7):874-82. PubMed ID: 16784988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
    Muris JJ; Cillessen SA; Vos W; van Houdt IS; Kummer JA; van Krieken JH; Jiwa NM; Jansen PM; Kluin-Nelemans HC; Ossenkoppele GJ; Gundy C; Meijer CJ; Oudejans JJ
    Blood; 2005 Apr; 105(7):2916-23. PubMed ID: 15576477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma.
    ten Berge RL; Dukers DF; Oudejans JJ; Pulford K; Ossenkoppele GJ; de Jong D; Miseré JF; Meijer CJ
    Blood; 1999 Apr; 93(8):2688-96. PubMed ID: 10194449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients.
    Wang YF; Yang YL; Gao ZF; Zhou CJ; Gregg X; Shi YF; Wang J; Yang XF; Ke XY
    J Hematol Oncol; 2012 Jul; 5():38. PubMed ID: 22769020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK+ lymphoma: clinico-pathological findings and outcome.
    Falini B; Pileri S; Zinzani PL; Carbone A; Zagonel V; Wolf-Peeters C; Verhoef G; Menestrina F; Todeschini G; Paulli M; Lazzarino M; Giardini R; Aiello A; Foss HD; Araujo I; Fizzotti M; Pelicci PG; Flenghi L; Martelli MF; Santucci A
    Blood; 1999 Apr; 93(8):2697-706. PubMed ID: 10194450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
    ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
    Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
    Rassidakis GZ; Sarris AH; Herling M; Ford RJ; Cabanillas F; McDonnell TJ; Medeiros LJ
    Am J Pathol; 2001 Aug; 159(2):527-35. PubMed ID: 11485911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic large cell lymphoma, ALK-negative.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.
    Suzuki R; Kagami Y; Takeuchi K; Kami M; Okamoto M; Ichinohasama R; Mori N; Kojima M; Yoshino T; Yamabe H; Shiota M; Mori S; Ogura M; Hamajima N; Seto M; Suchi T; Morishima Y; Nakamura S
    Blood; 2000 Nov; 96(9):2993-3000. PubMed ID: 11049976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of seven biological factors (Hsp90a, p53, MDM2, Bcl-2, Bax, Cytochrome C, and Cleaved caspase3) with clinical outcomes of ALK+ anaplastic large-cell lymphoma.
    Li HL; Huang XP; Zhou XH; Ji TH; Wu ZQ; Wang ZQ; Jiang HY; Liu FR; Zhao T
    Biomed Environ Sci; 2011 Dec; 24(6):630-41. PubMed ID: 22365399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-XL down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo.
    Coluccia AM; Perego S; Cleris L; Gunby RH; Passoni L; Marchesi E; Formelli F; Gambacorti-Passerini C
    Blood; 2004 Apr; 103(7):2787-94. PubMed ID: 14656879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.
    Schlette EJ; Medeiros LJ; Goy A; Lai R; Rassidakis GZ
    J Clin Oncol; 2004 May; 22(9):1682-8. PubMed ID: 15117990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
    Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
    J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.
    Ergin M; Denning MF; Izban KF; Amin HM; Martinez RL; Saeed S; Alkan S
    Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.